Filed Pursuant to Rule 424(b)(3)
Registration No. 333-258947
SUPPLEMENT, DATED SEPTEMBER 22, 2021, TO
PROXY STATEMENT/PROSPECTUS
![]() | | | ![]() |
This supplement is being mailed to the common stockholders of Capstead Mortgage Corporation (“Capstead”) who are eligible to vote at the special meeting of common stockholders of Capstead to be held on October 15, 2021 (the “Capstead special meeting”), and supplements the information contained in the proxy statement/prospectus, dated September 7, 2021 (the “proxy statement/prospectus”), filed by Benefit Street Partners Realty Trust, Inc. (“BSPRT”) and Capstead relating to the merger (the “Merger”) of Rodeo Sub I, LLC, a subsidiary of BSPRT (“Merger Sub”), and Capstead, with Merger Sub continuing as the surviving entity, as set forth in the Agreement and Plan of Merger, dated as of July 25, 2021 (as amended, the “Merger Agreement”), by and among BSPRT, Merger Sub, Capstead and Benefit Street Partners L.L.C., the external advisor of BSPRT (the “BSPRT Advisor”). Capitalized terms used herein but not defined herein shall have the meanings assigned to them in the proxy statement/prospectus.
At the Capstead special meeting, the Capstead common stockholders will be asked to (i) consider and vote on a proposal (the “Capstead Merger Proposal”) to approve the Merger and the other transactions contemplated by the Merger Agreement, (ii) consider and vote on a non-binding advisory proposal (the “Capstead Non-Binding Compensation Advisory Proposal”) to approve the compensation that may be paid or become payable to Capstead’s named executive officers that is based on or otherwise relates to the Merger and (iii) approve the adjournment of the Capstead special meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Capstead Merger Proposal (the “Capstead Adjournment Proposal”).
Except to the extent amended, revised or updated by the information contained herein, this supplement does not amend, revise or update any of the other information set forth in the proxy statement/prospectus.
The purpose of this supplement is to update and supplement the information in the proxy statement/prospectus with information regarding an amendment to the Merger Agreement (“Amendment No. 1”) dated September 22, 2021. As described in the proxy statement/prospectus, in order to enhance the stability of the combined company’s stock price after the closing of the Merger, the Merger Agreement required that, prior to the closing of the Merger, BSPRT effect a recapitalization that would have resulted in BSPRT’s currently outstanding common stock being split into Class A common stock (which would be listed at the closing of the Merger) and Class B common stock (which would not be listed but which would automatically convert to listed Class A shares six months after the listing of the Class A common stock).
BSPRT and Capstead recently determined that using preferred stock in the recapitalization instead of the proposed Class B common stock will more effectively achieve the recapitalization purpose of enhancing the stability of the combined company’s stock price after the closing of the Merger. Amendment No. 1 provides that BSPRT common stockholders shall receive Series F Convertible Preferred Stock (“BSPRT Series F Preferred Stock”) in the BSPRT recapitalization instead of Class B common stock. Like the originally proposed Class B common stock, the BSPRT Series F Preferred Stock will automatically convert on a one-for-one basis into BSPRT common stock six months after listing of the BSPRT common stock, and the BSPRT Series F Preferred Stock will have the same dividend and voting rights as the originally proposed Class B common stock. Amendment No. 1 does not impact the consideration to be paid in the Merger or any other term of the Merger Agreement.
The Capstead Board continues to unanimously recommend that the Capstead common stockholders vote “FOR” the Capstead Merger Proposal, “FOR” the Capstead Non-Binding Compensation Advisory Proposal and “FOR” the Capstead Adjournment Proposal. If you are a common stockholder of Capstead and have not already authorized a proxy for use at the Capstead special meeting, you are urged to do so promptly. No action in connection with this supplement is required by any Capstead common stockholder who has previously delivered a proxy and who does not wish to revoke or change that proxy. For more information about how to authorize a proxy or revoke a proxy or voting instructions, see “The Capstead Special Meeting-Record Date; Voting Rights; Proxies” beginning on page 156 of the proxy statement/prospectus.
This supplement, which forms part of a registration statement on Form S-4 filed by BSPRT with the SEC, constitutes a supplement to the prospectus of BSPRT for purposes of the Securities Act of 1933, as amended, with respect to the BSPRT common stock to be issued in connection with the Merger. This supplement also constitutes a supplement to the proxy statement of Capstead for purposes of the Securities Exchange Act of 1934, as amended.
You should read carefully and in their entirety this supplement and the proxy statement/prospectus and all accompanying annexes. You should review and consider carefully the matters discussed under the heading “Risk Factors” beginning on page 26 of the proxy statement/prospectus, as amended and supplemented by the information beginning on page 4 of this supplement.
Neither the SEC nor any state securities commission has passed upon the adequacy or accuracy of the accompanying supplement or the adequacy or accuracy of the proxy statement/prospectus. Any representation to the contrary is a criminal offense.